The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine. What to know.

The shot is approved for use between 32 and 36 weeks of pregnancy during the RSV season, which typically starts in September and runs through January in the United States. Also during meeting: RFK ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The RSV vaccination eligibility age has been lowered from 60 years to 50 years according to an update on the CDC website.

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the same family as the Ebola virus ...

Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...